Τόμος 23 (2009) – Τεύχος 2 – Άρθρο 4 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 23 (2009) – Issue 2 – Article 4 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Hypericum perforatum L.: a traditional remedy with new indications
Authors C. Sapounakis and C. Tesseromatis

Department of Pharmacology, Medical School, University of Athens Greece

Citation Sapounakis, C., Tesseromatis, C.: Hypericum perforatum L.: a traditional remedy with new indications, Epitheorese Klin. Farmakol. Farmakokinet. 23(2): 73-76 (2009)
Publication Date Accepted for publication (Final Version): July 1, 2009
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €) 

pharmakonpress[at]pharmakonpress[.]gr

Keywords Hypericum perforatum, depression, wound healing.
Other Terms review article
Summary Hypericum perforatum is a traditional remedy which derives from a plant belonging to the Hypericaceae family known as St. John’s Wort, currently undergoing extensive clinical and laboratory investigation. Hypericum perforatum has a complex and diverse chemical synthesis, including volatile oils (0.05 to 0.3%, such as α-pinene, and cineole), anthraquinones, carotenoids, cumarine, flavonoids (0.5-1.0%,hyperoside, quercetin, and rutin), naphthodianthrones (0.1-0.3%, 80-90% of which are hypericin and pseudohypericin), carbolic acids, phloroglucins (up to 3% hyperforin), xanthones, and proanthocyanidins. The plant possesses antiviral and antidepressant effects due to it’s constituents in naphthodianthrones, hypericin and pseudohypericin while hyperforin, and any flavonoid compounds may exert antidepressant properties. Hypericum perforatum has already been known in folk medicine as a successful wound healing remedy used for the preparation of various products for local application, focused on skin or mucosa injury of various origin.
References 1. Wichtl M.: Herbal Drugs and Phytopharmaceuticals. pp.273-275, CRCPress, Boca Raton, FL, 1994

2. Blumenthal M., Goldberg A., Brinckmann J.: Herbal Medicine. Pp. 359-366, Expanded Commission E Monographs. Integrative Medicine Communications, Newton, MA, 2000

3. Schulz V., Hansel R., Tyler V.E.: Rational Phytotherapy: A Physicians’ Guide to Herbal Medicine. Pp. 57-77, Springer-Verlag, Berlin, Germany, 2001

4. Chatterjee S.S., Bhattacharya S.K., Wonnemann M., Singer A., Muller W.: Hyperforin as a possible antidepressant component of Hypericum extracts. Life Sci. 63: 499-510 (1998)

5. Weber N.D., Murray B.K., North J.A., Wood S.G.: The antiviral agent hypericin has in vitro activity against HSV-1 through non-specific association with viral and cellular membranes. Antivir. Chem. Chemother. 5: 83-90 (1994)

6. Lenard J., Rabson A., Vanderoef R.: Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose Bengal: inhibition of fusion and syncytia formation. Proc. Natl. Acad. Sci. USA 90: 158-162 (1993)

7. Hadjur C., Richard M.J., Parat M.O., Favier A., Jardon P.: Photodynamically induced cytotoxicity of hypericin dye on human fibroblast cell line MRC5. J. Photochem. Photobiol. Biol. B 27:139-146 (1995)

8. Friede M., Henneicke von Zepelin H.H., Freudenstein J.: Differential therapy of mild to moderate depressive episodes (ICD-10 F 32.0; F32.1) with Hypericum perforatum. Pharmacopsychiatry 34: S38-S41 (2001)

9. Hypericum Depression Trial Study Group: Effect of Hypericum perforatum in major depressive disorder: a randomized controlled trial. JAMA 287: 1807-1814 (2002)

10. Thomas C., Pardini R.S.: Oxygen dependence of hypericin-induced phototoxicity to EMT6 mouse mammary carcinoma cells. Photochem. Photobiol. 55: 831-837 (1992)

11. Vandenbogaerde A.L., Delaey E.M., Vantieghem A.M., Himpens B.E., Merlevede W.J., de Witte P.A.: Cytotoxicity and antiproliferative effect of hypericin and derivatives after photosensitization. Photochem. Photobiol. 67: 119-125 (1998)

12. Schempp C.M., Kirkin V., Simon-Haarhaus B., Kersten A., Kiss J., Termeer C.C., Gilb B., Kaufmann T., Borner C., Sleeman J.P., Simon J.C.: Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from Hypericum perforatum that acts by induction of apoptosis. Oncogene 21: 1242-1250 (2002)

13. Lavagna S.M., Secci D., Chimenti P., Bonsignore L., Ottaviani A., Bizzari B.: Efficacy of Hypericum and Calendula oils in the epithelial reconstruction of surgical wounds in childbirth with caesarean section. Farmaco 56: 451-453 (2001)

14. Sapounakis C., Chatzigianni E., Goudelis A., Petsaros S., Seferos N., Rallis G., Tesseromatis C.: Hypericum perforatum induced acceleration on wound healing process. 3th International Conference on Oxidative Stress in Skin Medicine and Biology. Andros, Greece 21-24 2006

15. Beckman S.E., Sommi R.W., Switzer J.: Consumer use of Hypericum perforatum: a survey on effectiveness, safety, and tolerability. Pharmacotherapy 20: 568-574 (2000)

16.. Wang Z., Gorski J.C., Hamman M.A., Huang S.M., Lesko L.J., Hall S.D.: The effects of Hypericum perforatum on human cytochrome P450 activity. Clin. Pharmacol. Ther. 70: 317-326 (2001)

17. Woelk H., Burkhard G., Grunwald J.: Benefits and risks of the Hypericum extract LI 160: drug monitoring study with 3250 patients. J. Geriatr. Psychiatry Neurol. 7: S34-S38 (1994)

18. Blumenthal M., Busse W.R., Goldberg A.: The Complete Commission E Monographs. Pp. 214-215, Integrative Medicine Communications, Boston, MA, 1998

19. Lee A., Minhas R., Matsuda N., Lam M., Ito S.: The safety of Hypericum perforatum during breastfeeding. J. Clin. Psychiatry 64: 966-968 (2003)

20. Ahuis F.: Neues ber Johanniskraut [News on St. John’s Wort]. Deutsche Apotheker Zeitung 138: 1783-1785 (1998)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2009 – ANNUAL SUBSCRIPTION 2009
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

 

Bookmark the permalink.

Comments are closed.